Navigation Links
Important Information on Fibromyalgia and Access to Treatments
Date:9/2/2008

Examining the Foundation of Patient Driven Medicine

Note: September is Pain Awareness Month

SACRAMENTO, Calif., Sept. 2 /PRNewswire-USNewswire/ -- Insurance companies are denying Fibromyalgia patients proper access to treatments for their chronic pain condition. Doctors are having a difficult time getting their fibromyalgia patients the appropriate therapies. While there are treatments available, including the FDA fast tracked prescription medicine Lyrica and now Cymbalta, there is a serious lack of access to treatments. Basically, insurance companies, including Medi-Cal, are denying access, or at least making it very difficult, for patients to get prescribed treatments. Fibromyalgia is a real condition but due to lack of awareness and validation, Fibromyalgia patients are forced to continue to suffer with the pain and doctors are unduly limited when there are options for treatment.

Below is more information. We hope you will consider taking a closer look at this concerning issue.

Denial letters, contact information for patients and doctors and other background information can be provided upon request.

About Fibromyalgia

Fibromyalgia is the most common chronic widespread pain condition in the United States. Studies indicate that at least 6 million Americans suffer from Fibromyalgia, but estimates range as high as 10 to 12 million people. Between 80-90 percent of people diagnosed with Fibromyalgia are women.

Yet, while many people are unaware of this condition or even question it, for those who suffer from it managing the pain can be extremely difficult. The recognition of the condition as a real disease is critical to opening options for treatment because the prognosis for people with Fibromyalgia has never been better.

See links below to websites with more information about Fibromyalgia.

About Treatments for Fibromyalgia and Access Issues

Broad, individualized therapeutic strategies can be effective in helping to manage the condition. These may include lifestyle measures (such as exercise, nutrition and relaxation techniques), behavioral support, as well as drug therapy.

However, while treatments are available, including an FDA fast tracked prescription medicine, there is a serious lack of access to treatment for poor people, and doctors are having a difficult time getting their fibromyalgia patients the appropriate treatments.

Increasingly doctors are finding very few medicines their patients need are available on the Medi-Cal formulary, including the only prescription medicine for Fibromyalgia. Instead, the bureaucrats at Medi-Cal recommend we try alternative therapies first that have not been approved by the Food and Drug Administration for specific treatment of a condition. In the case of Fibromyalgia, they suggest doctors first try antidepressant medications.

This is a poignant example of a system which forces doctors to prescribe drugs that have not been proven to be effective or safe in treating a disease. Not only is this disturbing from the standpoint of jeopardizing patient quality of care, but doctors can't help but wonder about the potential legal and malpractice issues it creates.

Medicines differ from one another and patients react differently to different treatments. In a diverse state as California, it is critical medical practitioners are provided a wide array of tools to treat their Medi-Cal patients.

Trying to get anything other than over-the-counter medications is an absolute nightmare for doctors. When a drug is not on the Medi-Cal formulary, doctors are required to navigate a complicated and lengthy process of justifying why their patients should get the drug we think is best for them. This process known as Treatment Authorization Request (TAR) is cumbersome and punitive for patients. It takes significant time for doctors and their staff to assemble and process the paperwork; time they do not have, taking time away from patient care. This process creates barriers in their ability to treat their patients in the manner they feel is clinically appropriate. Furthermore, many retail chain drug stores refuse to process TAR requests on behalf of patients because they feel this is a cumbersome, paper driven undertaking. Finally, these TAR requests are not reviewed by licensed physicians with clinical expertise; instead they are reviewed by non-physician government employees.

Such bureaucracies ultimately drive up health care costs as each and every time a patient fails on an un-approved treatment they have to return for further medical therapy. Doctors are forced to select from treatments which may not be in the best interest of their individual patient, and patients are treated as guinea pigs, required to fail on therapies un-approved by the FDA.

An article ran in the Pittsburgh Post-Gazette (Fibromyalgia patients fight insurers over medication coverage, 7/13/08) illustrating similar issues and includes the National Fibromyalgia Association which is located in California. To read the full article visit:

http://www.post-gazette.com/pg/08195/896544-28.stm

For more information about Fibromyalgia visit:

Fibromyalgia Support Center: http://www.fibrocenter.com

American Chronic Pain Association: http://www.theacpa.org

National Fibromyalgia Association: http://www.fmaware.org

For more information or for contact info for doctors and patients please contact Jennifer Wonnacott at 916-444-8897.


'/>"/>
SOURCE FibroCenter.com
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Catholic Health Association Responds to Census Figures on the Uninsured: Important Not to Be Misled By Declining Uninsured - These Are Not Todays Numbers
2. Why Affordable HIV Testing Is More Important Than Ever: "HIV Epidemic 40% Higher Than Estimates"
3. Regence Video Cards Help Start Important Health Conversations With Friends, Family
4. Frontline Caregiver Coalition to Bush Administration: Stopping Pending $770 Million Medicare Cut Most Important 2008 Health Policy Issue
5. DIA And FDA To Host Two Important Critical Path Workshops
6. Education More Important Than Immigration to Solve Nursing Shortage, Research Shows
7. Behavioral Risk in the Workplace: Behavioral Risk Management Continues to be an Important Best Practice Area for Employers
8. Researchers confirm benzene-like electron delocalization of important molecule
9. Survey Indicates Lifestyle Change Is More Important Than Diets
10. Tim Russerts Death Provides Important Opportunity for News Media to Increase Public Awareness of How to Prevent Sudden Cardiac Arrest
11. Discovery of new signal pathway important to diabetes research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... provider of comprehensive treatment for eating disorders, is opening a brand new child ... provide individuals ages 8-17 and their families with even more specialized eating disorder ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... of Mehling Orthopedics and chief medical officer of Blue Horizon International (BHI), Brian ... Regeneration. The conference was held during May 5-6, 2016 in Chicago, IL, USA. ...
(Date:5/26/2016)... ... May 26, 2016 , ... Bunion Bootie , the manufacturer of the ... more than humbled by customer demand over the Mother’s Day Weekend promotion. So much ... that Bunion Bootie has completely replenished its inventory levels, it hopes to continue its ...
(Date:5/26/2016)... ... 26, 2016 , ... The introduction of our professional athletes coincides with the ... , “We are proud to introduce Meghan Klingenberg, defender and World Champion ... Quick, wide receiver for Los Angeles who was a second round selection in the ...
(Date:5/26/2016)... ... May 26, 2016 , ... May 2016 – Lips ... central to popular cosmetic improvement efforts. Record numbers of clients now ask about lip ... or pouty, says Kally Papantoniou, MD, of Advanced Dermatology P.C. , The ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016 A key trend ... the emergence of new treatments. Cardax, a development stage ... treatment. The therapy is expected to fulfil large unmet ... is conducting studies to develop new treatments for osteoarthritis. ... genes involved in osteoarthritis are being investigated, and early ...
(Date:5/26/2016)... , May 26, 2016   Change ... and analytics, network solutions and technology-enabled services ... it entered into a strategic channel partnership ... outpatient software solutions and revenue cycle management ... hospitals and rehabilitation clinics to optimize revenue, ...
(Date:5/25/2016)... PARIS , May 25,2016 ... with the near-infrared Cellvizio platform for urological and ... MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... important regulatory milestone in the US with the ... Food and Drug Administration (FDA). This new FDA ...
Breaking Medicine Technology: